142 related articles for article (PubMed ID: 7955912)
1. Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model.
Carbó N; Costelli P; Tessitore L; Bagby GJ; López-Soriano FJ; Baccino FM; Argilés JM
Clin Sci (Lond); 1994 Sep; 87(3):349-55. PubMed ID: 7955912
[TBL] [Abstract][Full Text] [Related]
2. Sequential changes in lipoprotein lipase activity and lipaemia induced by the Yoshida AH-130 ascites hepatoma in rats.
López-Soriano J; Argilés JM; López-Soriano FJ
Cancer Lett; 1997 Jun; 116(2):159-65. PubMed ID: 9215859
[TBL] [Abstract][Full Text] [Related]
3. Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
Dessì S; Batetta B; Spano O; Bagby GJ; Tessitore L; Costelli P; Baccino FM; Pani P; Argilès JM
Br J Cancer; 1995 Nov; 72(5):1138-43. PubMed ID: 7577459
[TBL] [Abstract][Full Text] [Related]
4. Lipid metabolism in rats bearing the Yoshida AH-130 ascites hepatoma.
López-Soriano J; Argilés JM; López-Soriano FJ
Mol Cell Biochem; 1996 Dec; 165(1):17-23. PubMed ID: 8974077
[TBL] [Abstract][Full Text] [Related]
5. Humoral mediation for cachexia in tumour-bearing rats.
Tessitore L; Costelli P; Baccino FM
Br J Cancer; 1993 Jan; 67(1):15-23. PubMed ID: 8427775
[TBL] [Abstract][Full Text] [Related]
6. Responses of serum lipids and adipose tissue lipases to lipopolysaccharide administration in normal and hepatoma-bearing rats.
Kawasaki M; Yagasaki K; Miura Y; Funabiki R
Biosci Biotechnol Biochem; 1996 Mar; 60(3):528-9. PubMed ID: 8901118
[TBL] [Abstract][Full Text] [Related]
7. Effects of the phosphodiesterase-IV inhibitor EMD 95832/3 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatoma.
Meijsing B; Carbó N; López-Soriano FJ; Argilés JM
Cancer Lett; 2002 Dec; 188(1-2):53-8. PubMed ID: 12406548
[TBL] [Abstract][Full Text] [Related]
8. alpha-Adrenergic receptors may contribute to the hypertriglyceridemia associated with tumour growth.
López-Soriano J; Carbó N; Costelli P; López-Soriano FJ; Argilés JM
Cancer Lett; 1996 Dec; 110(1-2):213-6. PubMed ID: 9018104
[TBL] [Abstract][Full Text] [Related]
9. Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator.
Ohara M; Tsutsumi K; Ohsawa N
Metabolism; 1998 Jan; 47(1):101-5. PubMed ID: 9440486
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.
Costelli P; Carbó N; Tessitore L; Bagby GJ; Lopez-Soriano FJ; Argilés JM; Baccino FM
J Clin Invest; 1993 Dec; 92(6):2783-9. PubMed ID: 8254032
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth.
Costelli P; Llovera M; López-Soriano J; Carbó N; Tessitore L; López-Soriano FJ; Baccino FM; Argilés JM
Cancer Lett; 1995 Oct; 97(1):25-32. PubMed ID: 7585474
[TBL] [Abstract][Full Text] [Related]
12. Alterations of lipid and cholesterol metabolism in cachectic tumor-bearing rats are prevented by insulin.
Costelli P; Tessitore L; Batetta B; Mulas MF; Spano O; Pani P; Baccino FM; Dessì S
J Nutr; 1999 Mar; 129(3):700-6. PubMed ID: 10082777
[TBL] [Abstract][Full Text] [Related]
13. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia.
Feingold KR; Soued M; Staprans I; Gavin LA; Donahue ME; Huang BJ; Moser AH; Gulli R; Grunfeld C
J Clin Invest; 1989 Apr; 83(4):1116-21. PubMed ID: 2703526
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the changes in lipid metabolism between hepatoma-bearing and lipopolysaccharide-treated rats.
Kawasaki M; Yagasaki K; Miura Y; Funabiki R
Biosci Biotechnol Biochem; 2004 Jan; 68(1):72-8. PubMed ID: 14745166
[TBL] [Abstract][Full Text] [Related]
15. Marked hyperlipidaemia in rats bearing the Yoshida AH-130 ascites hepatoma.
Lopez-Soriano J; Argiles JM; Lopez-Soriano FJ
Biochem Soc Trans; 1995 Aug; 23(3):492S. PubMed ID: 8566392
[No Abstract] [Full Text] [Related]
16. Lack of effect of the cytokine suppressive agent FR167653 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatoma.
Busquets S; Alvarez B; van Royen M; Carbó N; López-Soriano FJ; Argilés JM
Cancer Lett; 2000 Aug; 157(1):99-103. PubMed ID: 10893448
[TBL] [Abstract][Full Text] [Related]
17. Lipid metabolism in tumour-bearing mice: studies with knockout mice for tumour necrosis factor receptor 1 protein.
López-Soriano J; Llovera M; Carbó N; García-Martínez C; López-Soriano FJ; Argiles JM
Mol Cell Endocrinol; 1997 Sep; 132(1-2):93-9. PubMed ID: 9324050
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific effects of rapid tumour growth on lipid metabolism in the rat during lactation and on litter removal.
Evans RD; Williamson DH
Biochem J; 1988 May; 252(1):65-72. PubMed ID: 3421910
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats.
Llovera M; Carbó N; García-Martínez C; Costelli P; Tessitore L; Baccino FM; Agell N; Bagby GJ; López-Soriano FJ; Argilés JM
Biochem Biophys Res Commun; 1996 Apr; 221(3):653-5. PubMed ID: 8630016
[TBL] [Abstract][Full Text] [Related]
20. Effect of endurance training upon lipid metabolism in the liver of cachectic tumour-bearing rats.
Lira FS; Tavares FL; Yamashita AS; Koyama CH; Alves MJ; Caperuto EC; Batista ML; Seelaender M
Cell Biochem Funct; 2008 Aug; 26(6):701-8. PubMed ID: 18636434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
